Real Time
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,8995 EUR | +2,10% | +2,10% | -12,75% |
Vakgebied
Pharming Group N.V. bedient patiënten in meer dan 30 markten in Noord-Amerika, Europa, het Midden-Oosten, Afrika en Azië/Pacific.
Aantal werknemers: 382
Verkoop per activiteit
EUR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Recombinant Human C1 Esterase Inhibitor
100,0
%
| 196 | 100,0 % | 227 | 100,0 % | +15,98% |
Verkoop per regio
EUR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
97,5
%
| 190 | 97,3 % | 221 | 97,5 % | +16,17% |
Europe and Rest of World
2,5
%
| - | - | 6 | 2,5 % | - |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Sijmen de Vries
CEO | Chief Executive Officer | 65 | 13-10-08 |
Jeroen Wakkerman
DFI | Director of Finance/CFO | 55 | 16-11-20 |
Anurag Relan
CTO | Chief Tech/Sci/R&D Officer | 52 | - |
Mireille Sanders
COO | Chief Operating Officer | 56 | 01-05-19 |
Compliance Officer | 60 | 01-04-20 | |
Michael Levitan
IRC | Investor Relations Contact | 66 | - |
Stephen Toor
PRN | Corporate Officer/Principal | 52 | 15-12-20 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Mark Pykett
BRD | Director/Board Member | 60 | 11-12-20 |
Leonard Kruimer
BRD | Director/Board Member | 66 | 19-05-21 |
Sijmen de Vries
CEO | Chief Executive Officer | 65 | 13-10-08 |
Steven Baert
BRD | Director/Board Member | 50 | 01-04-21 |
Deborah Jorn
BRD | Director/Board Member | 66 | 22-05-19 |
Barbara Yanni
BRD | Director/Board Member | 69 | 11-12-20 |
Director/Board Member | 58 | 19-05-21 | |
Richard Peters
CHM | Chairman | 61 | 25-09-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 671 073 243 | 655 383 865 ( 97,66 %) | 0 | 97,66 % |
Bedrijfsgegevens
Sector
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-13,34% | 636 mln. | |
+25,76% | 556 mld. | |
-6,33% | 354 mld. | |
+19,90% | 331 mld. | |
+7,95% | 296 mld. | |
+13,07% | 233 mld. | |
+5,33% | 201 mld. | |
-9,98% | 193 mld. | |
-12,26% | 143 mld. | |
-6,47% | 144 mld. |
- Beurs
- Aandelen
- Koers PHARM
- Onderneming Pharming Group N.V.